Thank you to the many front-line workers and organizations working tirelessly to help in these difficult days. While we are still actively recruiting for the CHARGE study, please be aware that our sites may be particularly busy at this time or adjusting their usual practice to better protect the health and safety of site staff and study participants. Please find updates on Biogen’s response to COVID-19 here.
Please follow your local public health department’s guidance for reducing the risk of infection with COVID-19. You can also visit the Centers for Disease Control and Prevention and World Health Organization websites for more information.
If so, consider CHARGE - a clinical trial investigating potential treatment options for children with RRMS. We'll be asking if the investigational use of a drug is safe and effective for children (ages 10-17) with RRMS.
This link will take you away from a Biogen regulated website.